Although the incidence of composite adverse perinatal outcomes (CAPO) was higher in the PCOS group (43.4%) than in the non-PCOS group (35.2%), this difference did not reach statistical significance ( p = 0.132) ( Table 2 ). 3.4.
← all excerpts
Impact of Elevated AMH Levels on Maternal and Perinatal Outcomes in IVF Pregnancies with PCOS.
1
0.1320
0.1320